about
Localization of the genes for histatins to human chromosome 4q13 and tissue distribution of the mRNAsStructural relationship between human salivary histatinsSecretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitroHIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors.Antiviral activities in human salivaEnhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patientsPositive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisThe anti-HIV-1 activity associated with saliva.Counseling patients about HIV risk from oral sexComparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluidsThe role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.Oral diseases in HIV-1 infection.Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and SalivaAnatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals.Proline-rich tandem repeats of antibody complementarity-determining regions bind and neutralize human immunodeficiency virus type 1 particlesHIV-related infections of the oral cavity.Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva.Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmissionHantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome.Identification of human immunodeficiency virus type 1 (HIV-1) gp120-binding sites on scavenger receptor cysteine rich 1 (SRCR1) domain of gp340.AIDS and HIV-1 infection: clinical entities in geriatric dentistry.Saliva: a reliable sample matrix in bioanalytics.Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.Hantavirus-specific IgA in saliva and viral antigen in the parotid gland in patients with hemorrhagic fever with renal syndrome.Antiviral effect of human saliva against hantavirus.HIV infection and the dentist. 1. The presence of HIV in saliva and its implications to dental practice.Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?Modulation of herpes simplex virus type 1 replication by human salivary secretions.Heparin-binding domain of human fibronectin binds HIV-1 gp120/160 and reduces virus infectivity.Submandibular salivary proteases: lack of a role in anti-HIV activity.Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients.
P2860
Q24678074-3ECB460A-8324-4B17-81D0-4B2E89C0D056Q28276374-F25B2FC7-B41F-4CC3-8705-B3FD649D5FA7Q28293679-B9D3AD01-CE0B-4E11-9636-317FDB09E0F9Q33638612-11DE46F7-F5C6-42C7-A898-CA3395085413Q33856840-56799815-D98A-4F28-B88E-6514A4F5C70EQ33997956-A3AD65D9-4BE4-42AC-AC30-A223A9C3018EQ34010283-D02DA741-5DCF-4499-BB57-7C1A8244DFB9Q34738486-10FF5D01-9027-4CC3-9AF1-130ECCB7FC69Q34753877-722A571C-725F-4019-9204-FA662C950AD8Q35075174-9B41265D-3455-4DA4-B937-6E38A93BACBAQ35185496-A2A2677D-FCE0-4D91-A1CD-4EC8CEC02054Q35679704-15CBFD0E-7DE8-4C79-B263-DCD048D00D0CQ35686903-08A06198-AF5C-47BA-B6DB-0084773824EEQ35764264-E690A098-F091-4B30-A0E1-8DEDEE4BA677Q35865811-81753425-C5A6-4B6B-95D2-3585FB2A987BQ35869342-26D539ED-F70D-4267-A4C2-607738D726BBQ36043918-7F67BAAF-097C-4144-9046-A49CAC99E5E6Q36381031-B037F08E-0491-4305-946B-8DAB7E584EF4Q36522664-914F2458-E520-4482-8B50-BF98053BA7D4Q36944758-0C7E434B-2E94-486B-9D1E-ABD0B6B9AC2EQ37042152-2C0A41BE-E70F-4FF8-BBA4-BAF1C424C140Q38263048-A7F7E517-8292-47E5-B74E-5B7FAB840F8BQ39306678-75BD3C8B-A84F-456A-AC2B-73E1D7C13A9FQ39402553-BBE85E47-A514-49DE-83DF-2464DBF5D6C4Q40332455-8211572C-D6D7-4D16-A6A7-4E0D89D90753Q40403706-C13EA409-3465-4F8E-A34A-B00C16BCE515Q40664942-CFA0D94F-EF64-428B-B26A-2D4B396B9CA8Q40731786-D217ADF8-662E-463A-BB56-2C6A6B8FC14FQ41697048-0746C370-3254-41F7-A2B1-ECEF9219D073Q41922735-6CC1455A-0DBB-4D1A-A537-1DE58C1BADA1Q44857279-E95AB2AF-7A66-4ABF-A247-021235FC2C57Q45758331-638022FB-D636-4B13-A84C-CDD2FF302BDDQ47849587-FEE71FE1-0E85-45C7-8879-537CE6221534Q51829152-EEA48267-03BB-49FE-8413-66A87C6378F3
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Saliva inhibits HIV-1 infectivity.
@en
Saliva inhibits HIV-1 infectivity.
@nl
type
label
Saliva inhibits HIV-1 infectivity.
@en
Saliva inhibits HIV-1 infectivity.
@nl
prefLabel
Saliva inhibits HIV-1 infectivity.
@en
Saliva inhibits HIV-1 infectivity.
@nl
P2093
P1476
Saliva inhibits HIV-1 infectivity.
@en
P2093
P304
P356
10.14219/JADA.ARCHIVE.1988.0002
P407
P577
1988-05-01T00:00:00Z